Interest Income Expense - Initiator Pharma A/S (STO:INIT) - Alpha Spread
I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.35 SEK -2% Market Closed
Market Cap: 388.9m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Initiator Pharma A/S
Interest Income Expense Peer Comparison

Comparables:
GMAB
GLTO
ASND
B
BAVA
BIOPOR

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Interest Income Expense
-kr677k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
NASDAQ:GMAB
Interest Income Expense
kr1.6B
CAGR 3-Years
643%
CAGR 5-Years
53%
CAGR 10-Years
65%
Galecto Inc
NASDAQ:GLTO
Interest Income Expense
$1.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Interest Income Expense
-€126.9m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
-73%
B
Bavarian Nordic A/S
CSE:BAVA
Interest Income Expense
kr93.2m
CAGR 3-Years
N/A
CAGR 5-Years
56%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Interest Income Expense
kr558k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Initiator Pharma A/S's Interest Income Expense?
Interest Income Expense
-677k DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Interest Income Expense amounts to -677k DKK.

Back to Top